BlackRock Fund Advisors’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$12.9M Buy
91,757
+15,273
+20% +$2.15M ﹤0.01% 2432
2016
Q3
$11.2M Buy
76,484
+5,165
+7% +$754K ﹤0.01% 2396
2016
Q2
$7.18M Buy
71,319
+794
+1% +$79.9K ﹤0.01% 2602
2016
Q1
$9.44M Buy
70,525
+1,222
+2% +$163K ﹤0.01% 2383
2015
Q4
$13.8M Sell
69,303
-5,058
-7% -$1.01M ﹤0.01% 2264
2015
Q3
$11.7M Buy
74,361
+3,386
+5% +$535K ﹤0.01% 2303
2015
Q2
$29M Buy
70,975
+13,005
+22% +$5.31M 0.01% 1883
2015
Q1
$26.6M Buy
57,970
+6,944
+14% +$3.19M 0.01% 1914
2014
Q4
$28.6M Buy
51,026
+29,533
+137% +$16.6M 0.01% 1846
2014
Q3
$11.3M Buy
21,493
+1,087
+5% +$570K ﹤0.01% 2280
2014
Q2
$14.2M Buy
20,406
+5,669
+38% +$3.96M ﹤0.01% 2200
2014
Q1
$6.83M Buy
14,737
+523
+4% +$242K ﹤0.01% 2626
2013
Q4
$4.89M Buy
+14,214
New +$4.89M ﹤0.01% 2840